Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. It focusses on various therapeutic areas, in…
Biotechnology
CN, Nanjing [HQ]
Acquisitions · S-4
Mergers & Acquisitions
M&A Details · Industry · Urgent
M&A Deals · Breakdown
Simcere Pharmaceutical Group Limited has no acquisition track records yet.
M&A Deals · History
Simcere Pharmaceutical Group Limited has no acquisition track records yet.
Simcere Pharmaceutical Group Limited can't present any M&A detail analysis.
Try it with one of the Urgent M&A Deals by clicking "Details".
Try it with one of the Urgent M&A Deals by clicking "Details".
M&A Deals · Within Industry
Keep an eye on latest M&A deals done inside the Biotechnology Industry.
M&A Deals · Urgent
Act, dont react; Track the most urgent M&A deals across all industries
Details
Details
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
Details
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00